(Date:11/23/2009)...N,Nov.23/PRNewswire-USNewswire/--FebeDurango-Rueda...toparticipatinginaschemetodefraudtheExport-ImportB...,announcedAssistantAttorneyGeneraloftheCriminalDiv...L.GratacosoftheEx-ImBank,OfficeoftheInspectorGener...RobertsinU.S.DistrictCourtinWashingtontoaone-count...
(Date:11/23/2009)...Ga.,Nov.23/PRNewswire-FirstCall/--Immucor,Inc.(Nas...ument-reagentsystemstothebloodtransfusionindustry,...rJaffray21stAnnualHealthCareConferenceinNewYork,NY... TheCompany,spresentationisscheduledforTuesday,Dec...entationwillbeavailablethroughthe"AboutUs--Investo...
(Date:11/23/2009)...AKS,Calif.,Nov.23/PRNewswire-FirstCall/--Amgen(Nas...gforBestOverallPipelineandforBestNewDrugforNplate&..., TheBestOverallPipelineawardwaspresentedtoAmgenby...etpotentialofthecompany,spipeline,aswellasitsmixof...dges,Amgen,spipelineisnotableforitsfocusonunmetcli...
Breaking Medicine Technology:Colombian National Pleads Guilty to Role in Defrauding the Export-Import Bank of the United States of More Than $1 Million 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 2Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 3Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 4Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 5Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards 6Image Sensors 2009 Announces Final Program and New Interactive Brochure 52852 1Image Sensors 2009 Announces Final Program and New Interactive Brochure 52852 2Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 1Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 2Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 3Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 4Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 5Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO 01 Trial in Secondary Progressive Multiple Sclerosis 4785 6Many Heart Attack Patients Not Referred to Cardiac Rehab 52843 1Many Heart Attack Patients Not Referred to Cardiac Rehab 52843 2Many Heart Attack Patients Not Referred to Cardiac Rehab 52843 3..., April 16 Emisphere,Technologies, Inc. (Nasdaq: ...l in vivo studies using dogs further demonstrate t...the absorption of oral B12. These,data confirm in ...f of,concept studies conducted in rats., "These a...e in our,plans to commercialize our eligen(R) tech...
... April 16 Anthera Pharmaceuticals,Inc., a private...inflammatory drugs, announced today that after com...rently available, an independent Data Safety,Monit...Phase II clinical,trial, known as the IMPACTS (Inv...cute ChesT Syndrome) Study can continue under the ...
Other Medicine Technology:Proof of Concept Study in Second Species Demonstrates Increase in Absorption of Oral B12 Using Emisphere Technology 2DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 2(Date:11/23/2009)...ight ease the problem, researchers say , ...tle up their anger over unfair treatment at work c...indicates. , Men who consistently failed to exp... worker or supervisor were more than twice as like...as those who vented their anger, claims a report i...
(Date:11/23/2009)...ire-FirstCall/--InfoLogix,Inc.(Nasdaq: IFLG ),alea...sforthehealthcareandcommercialindustries,announced...esatSiemensHealthServices,hasjoinedInfoLogixasVice...o: http://www.newscom.com/cgi-bin/prnh/20090618/NE...careServicesforInfoLogix,Mr.Waywillberesponsiblefo...
(Date:11/23/2009)...re-USNewswire/--TheAmericanSocietyofHematology(ASH...tion,andmediacompany,arelaunching"ExploretheMyster...interestinthefieldsofscienceandmedicine,inaddition...ematology. ,, "Manyhematologistsmayrememberwatc...hichmadelearningaboutbloodreallyfun,"statedNancyBe...
(Date:11/23/2009)...s and survivors treated with chemotherapy suffer i...ic conditions, hindering patients, ability to full...ty of Rochester Medical Center. , A study of 823...ubles at nearly three times the rate of the genera...unger patients and those with lung and breast canc...
(Date:11/23/2009)...essionals enjoy a pay raise for a job well done. B...lth care performance may actually backfire. , ...nce ratings for 25 medical groups across Californi... statewide pay-for-performance program in 2004 bu...vity. , Reporting in the December edition of ...
Breaking Medicine News(10 mins):Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3...ps patients with bladder cancer live longer, accor...ho receive chemotherapy plus surgery //survive lon...all this an important advance in the treatment of ... Cancer Society, approximately 57,000 people will ...
...ay want to leave the alcohol at home next time you...unburn.Researchers found those who consumed //alco...drinkers and were more likely to need a pain relie...rs. However, drinkers did not report spending more...
...ty should be the treatment of choice for heart att...//go to doesn't offer angioplasty services and the...reatment.
Research has shown heart attack patie...ot-busting drug therapy called fibrinolysis.
Da...
...f heart disease may be present early in life, say ...between body mass index and C-reactive //protein l...r for cardiovascular disease in adults.
Resea...l S. Ford, M.D., M.P.H., from the Centers for Dise...
...rt taking painkillers during pregnancy increases t...atory drugs, which include// aspirin and ibuprofen...ften used by pregnant women.
Doctors interview...e pregnant, reproductive history, and potential ri...
...earchers say giving heroin to opiate addicts can h...archers in the Netherlands conducted two separate ...t respond to methadone maintenance treatment. Part...er 12 months of methadone treatment alone, 12 mont...
Other Medicine News:...r defibrillators (ICDs) are designed to treat pati... arrhythmia. The size and physiologic shape of the...insertion and contribute to patient comfort., ,...rietary RHYTHM ID discrimination technology to hel...
Vitality DS
...em is the most advanced and versatile high resolut...allows users to perform high frequency ultrasound ...r 50MHz probes or high resolution posterior segmen...The Macintosh computer provides for image display ...
...ration. Tone-assisted measurement notifies the ope... recorded. The AL-100 takes up to 10 readings, for...xial lengths from 15-40mm with an accuracy of 0.1m...rmal, Aphakic, Pseudophakic and Dense Cataract. Ps...
Medicine Products: